Stocks · Health care · Surgical & Medical Instruments & Apparatus

SeaStar Medical Holding Corp

ICU Clue Score61
United States Fiscal year ends December CIK 0001831868
$3.61 +3.44% Close, 9 Oct 2026
Price $3.61 +668.09% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Oct 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−4.4Net income−4.6EPS, diluted−0.63Fiscal year 2022Operating income−11.6Net income−12.2EPS, diluted−1.48Fiscal year 2023Revenue0.0Operating income−14.2Net income−26.2EPS, diluted−30.26Fiscal year 2024Revenue0.1Operating income−17.8Net income−24.8EPS, diluted−6.63Fiscal year 2025Revenue1.2 +814.1%Operating income−12.2Net income−12.2
FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 0.1 1.2
Growth +814.1%
Operating income −4.4 −11.6 −14.2 −17.8 −12.2
Net income −4.6 −12.2 −26.2 −24.8 −12.2
Growth
EPS, diluted −0.63 −1.48 −30.26 −6.63 n/a

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Gross margin100.0%Operating margin−13,216.3%Net margin−18,392.6%Fiscal year 2025Gross margin95.7%Operating margin−986.6%Net margin−984.6%
FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a 100.0% 95.7%
Operating margin n/a n/a n/a −13,216.3% −986.6%
Net margin n/a n/a n/a −18,392.6% −984.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2021Operating cash flow−5.1Fiscal year 2022Operating cash flow−7.8Fiscal year 2023Operating cash flow−10.3Fiscal year 2024Operating cash flow−16.0Fiscal year 2025Operating cash flow−13.6
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.1 −7.8 −10.3 −16.0 −13.6

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash0.1Shareholders’ equity−2.8Fiscal year 2022Cash0.0Total debt8.8Net cash (debt)−8.8Shareholders’ equity−20.8Fiscal year 2023Cash0.2Total debt4.7Net cash (debt)−4.5Shareholders’ equity−13.9Fiscal year 2024Cash1.8Total debt0.6Net cash (debt)1.2Shareholders’ equity−2.2Fiscal year 2025Shareholders’ equity10.4
FY2021FY2022FY2023FY2024FY2025
Cash 0.1 0.0 0.2 1.8 n/a
Total debt n/a 8.8 4.7 0.6 n/a
Net cash (debt) n/a −8.8 −4.5 1.2 n/a
Shareholders’ equity −2.8 −20.8 −13.9 −2.2 10.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−5.1 −7.8 −10.3 −16.0 −13.6
Growth
Investment
−105.6 n/a n/a n/a n/a
Financing
2.8 7.3 10.4 17.7 23.8

Capital expenditure, dividends and buybacks are shown as money out, so negative.